NeoGenomics, Inc.: NeoGenomics Inc. Announces Partnership wi

FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today

Related Keywords

Fort Myers , Florida , United States , Georgia , Tampa , North Carolina , United Kingdom , Texas , Research Triangle Park , Atlanta , California , San Diego , Arizona , Tennessee , Singapore , Phoenix , Houston , Aliso Viejo , Cambridge , Cambridgeshire , Switzerland , Derek Lyle , Eli Lilly , Anthony Nino Sireci , Clinical Division Of Neogenomics , Neogenomics Inc , Lilly Lung Cancer Sponsored Testing Program , Company Pharma Services Division , Nasdaq , Company Annual Report On Form , Diagnostics Development , Lungliquid Biopsy , Chief Medical Officer , Clinical Division , Generation Sequencing , Vice President , Clinical Biomarkers , Loxo Oncology , Pharma Services Division , Privacy Practices , Private Securities Litigation Reform Act , Annual Report , Neogenomics , Nnounces , Partnership , Illy , Young , Dancer , Sponsored , Testing , Program , Tilizing , Eotype , Essay ,